CoChat
Sign Up
Cited by 180Neonatal Health and BiochemistryRedox biology and oxidative stressPharmacological Effects and Toxicity Studies

The DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index.

An embryoprotective role for glucose‐6‐phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis

NICOL, CHRISTOPHER J., ZIELENSKI, JULIAN, TSUI, LAP‐CHEE, WELLS, PETER G.·2000·The FASEB Journal
DOI 10.1096/fasebj.14.1.111
Open this paper in CoChat — free account

Abstract

The primary recognized health risk from common deficiencies in glucose‐6‐phosphate dehydrogenase (G6PD), a cytoprotective enzyme for oxidative stress, is red blood cell hemolysis. Here we show that litters from untreated pregnant mutant mice with a hereditary G6PD deficiency had increased prenatal (fetal resorptions) and postnatal death. When treated with the anticonvulsant drug phenytoin, a human teratogen that is commonly used in pregnant women and causes embryonic oxidative stress, G6PD‐deficient dams had higher embryonic DNA oxidation and more fetal death and birth defects. The reported G6PD gene mutation was confirmed and used to genotype fetal resorptions, which were primarily G6PD deficient. This is the first evidence that G6PD is a developmentally critical cytoprotective enzyme for both endogenous and xenobiotic‐initiated embryopathic oxidative stress and DNA damage. G6PD deficiencies accordingly may have a broader biological relevance as important determinants of infertility, in utero and postnatal death, and teratogenesis.—Nicol, C. J., Zielenski, J., Tsui, L.‐C., Wells, P. G. An embryoprotective role for glucose‐6‐phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14, 111–127(2000)

Overview

Integrity signals

Registry

Crossref · 10.1096/fasebj.14.1.111

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 7

  1. Wells P. G., 1996, Handbook of Experimental Pharmacology: Drug Toxicity in Embryonic Development, 453
  2. Luzzatto L., 1995, The Metabolic and Molecular Basis of Inherited Disease, 3367
  3. Winn L. M., 1995, Free radical‐mediated mechanisms of anticonvulsant teratogenicity, Eur. J. Neurol., 2, 5
  4. Laposa R. R., 1995, Preliminary evaluation of phenytoin teratogenicity in transgenic mice deficient in the p53 tumor suppressor gene, Fundam. Appl. Toxicol., 15, 161
  5. Laposa R. R., 1996, Enhanced phenytoin embryopathy in p53‐deficient mice: characterisation of embryonic p53 genotype and the p53, p21 and Bax DNA damage response proteins, Fundam. Appl. Toxicol., 30, 195
  6. Mayes P.A., 1996, Harper's Biochemistry, 216
  7. Werth G., 1967, Inheritable glucose‐6‐phos‐phate dehydrogenase deficiency in erythrocytes of rats, Klin. Wochenschr., 45, 265

Cited by

Sorted by citations

See all 180

Related

See all

Metadata

Authors
NICOL, C. J., ZIELENSKI, J., TSUI, L., & WELLS, P. G.
Affiliations
  • University of Toronto (CA)
  • Hospital for Sick Children (CA)
Corresponding author
WELLS, PETER G.
ORCID
Venue
The FASEB Journal
Publisher
Wiley
Published
2000-01
Volume
14
Issue
1
Pages
111-127
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
DOI
10.1096/fasebj.14.1.111
OpenAlex
W1535461485
Cited by
180
References
70
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 12 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 7 · 2012: 8
FWCI
7.24
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
Society of Toxicology
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
glucose-6-phosphate dehydrogenase, glucose-6-phosphate dehydrogenase deficiency, phenytoin, fetal resorption, fetal death, congenital malformations, cytoprotection, pregnancy
MeSH terms
Animals, Base Sequence, DNA Damage, Embryo, Mammalian, Female, Embryonic and Fetal Development, Glucosephosphate Dehydrogenase, Heterozygote, Homozygote, Mice, Mutant Strains, Phenotype, Pregnancy, Teratogens, DNA Primers, Oxidative Stress, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review